Cargando…

Insights to Clinical Use of Serial Determination in Titers of Cyclic Citrullinated Peptide Autoantibodies

Anti-cyclic citrullinated peptide (CCP) antibody is a useful marker for the diagnosis and prognosis of rheumatoid arthritis (RA). Recently, clinical significance of follow-up in anti-CCP antibody titer has been pointed out. Thus, we investigated the serial determination in anti-CCP antibodies titer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kogure, Toshiaki, Tatsumi, Takeshi, Fujinaga, Hiroshi, Niizawa, Atsushi, Terasawa, Katsutoshi
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2007
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1847473/ https://www.ncbi.nlm.nih.gov/pubmed/17497027 http://dx.doi.org/10.1155/2007/12367

Ejemplares similares

No Correlation Exists between Disease Activity and the Expression of Killer-Cell Immunoglobulin-Like Receptors in Patients with Rheumatoid Arthritis
por: Kogure, Toshiaki, et al.
Publicado: (2007)

Effect of Kampo Medicine on Pain and Range of Motion of Osteoarthritis of the Hip Accompanied by Acetabular Dysplasia: Case Report and Literature Review
por: Kogure, Toshiaki, et al.
Publicado: (2011)

The Observation of Humoral Responses after Influenza Vaccination in Patients with Rheumatoid Arthritis Treated with Japanese Oriental (Kampo) Medicine: An Observational Study
por: Kogure, Toshiaki, et al.
Publicado: (2012)

Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis
por: Meyer, Olivier, et al.
Publicado: (2006)

Anti-keratin and anti-cyclic citrullinated peptide autoantibodies in patients with juvenile idiopathic arthritis
por: Vavrinec, J, et al.
Publicado: (2002)

Killer-cell inhibitory receptors, CD158a/b, are upregulated by interleukin-2, but not interferon-gamma or interleukin-4.
por: Kogure, T, et al.
Publicado: (1999)

Significance of Anti-cyclic Citrullinated Peptide Autoantibodies in Immune-mediated Inflammatory Skin Disorders with and without Arthritis
por: Grover, Chander, et al.
Publicado: (2016)

Investigation of the relationship between the HLADRB1 genotype and the presence of autoantibody to cyclic-citrullinated peptide in patients with rheumatoid arthritis
por: Brózik, M, et al.
Publicado: (2005)

Enhanced neutrophil phagocytic capacity in rheumatoid arthritis related to the autoantibodies rheumatoid factor and anti-cyclic citrullinated peptides
por: de Siqueira, Marcelo Bogliolo Piancastelli, et al.
Publicado: (2015)

The anti-cyclic citrullinated peptide response in tuberculosis patients is not citrulline-dependent and sensitive to treatment
por: Elkayam, Ori, et al.
Publicado: (2010)

Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCP) affects severity of rheumatoid arthritis
por: van Gaalen, FA, et al.
Publicado: (2004)

Association of human leukocyte antigen-DRB1 with anti-cyclic citrullinated peptide autoantibodies in Saudi patients with rheumatoid arthritis
por: Alrogy, Abdullah, et al.
Publicado: (2017)

Assessment of anti-cyclic citrullinated peptide in psoriatic arthritis
por: Abdel Fattah, Nermeen SA, et al.
Publicado: (2009)

Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study
por: Atzeni, Fabiola, et al.
Publicado: (2006)

RE: Association of human leukocyte antigen-DRB1 with anti-cyclic citrullinated peptide autoantibodies in Saudi patients with rheumatoid arthritis
por: Adwan, Marwan Hmoud
Publicado: (2017)

Citrullinated Peptides as a Substrate for the Detection of Rheumatoid Arthritis-Specific Autoantibodies
por: van Venrooij, Walther J
Publicado: (2000)

Pathogenic Role of Circulating Citrullinated Antigens and Anti-Cyclic Monoclonal Citrullinated Peptide Antibodies in Rheumatoid Arthritis
por: Won, Pureun, et al.
Publicado: (2021)

Presence of anti-cyclic citrullinated peptide antibody isotypes in juvenile idiopathic arthritis synovial fluid indicates autoantibody production at the site of inflammation
por: Gilliam, Brooke E, et al.
Publicado: (2012)

Asbestos exposure and autoantibody titers
por: Lee, Eunsoo, et al.
Publicado: (2020)

Prevalence of non-rheumatoid arthritis-associated autoantibodies in sera of anti-cyclic citrulline antibody-positive patients
por: Brozik, M, et al.
Publicado: (2005)

Anti-Cyclic Citrullinated Peptide Antibody-Positive Meningoencephalitis in the Preclinical Period of Rheumatoid Arthritis
por: Shibahara, Tomoya, et al.
Publicado: (2016)

The effect of infliximab on rheumatoid factor and anti-citrullinated cyclic peptide antibodies
por: van Damme, N, et al.
Publicado: (2002)

Anti-Cyclic Citrullinated Peptide Antibodies and Joint Involvement in Behçet's Disease
por: Cho, Sung Bin, et al.
Publicado: (2012)

Anti-cyclic citrullinated peptide antibodies in children with Juvenile Idiopathic Arthritis
por: Hamooda, Mohamed, et al.
Publicado: (2016)

A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis
por: Berglin, Ewa, et al.
Publicado: (2004)

Pattern of thyroid, celiac, and anti-cyclic citrullinated peptide autoantibodies coexistence with type 1 diabetes mellitus in patients from Southwestern Saudi Arabia
por: Al-Hakami, Ahmed M.
Publicado: (2016)

Gene expression of cell surface antigens in the early phase of murine influenza pneumonia determined by a cDNA expression array technique.
por: Sakai, Shinya, et al.
Publicado: (2002)

Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study
por: Bizzaro, Nicola, et al.
Publicado: (2013)

Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis
por: Tebo, Anne E, et al.
Publicado: (2012)

Development of synthetic anti-cyclic citrullinated peptide antibody and its arthritogenic role
por: Kim, Youngkyun, et al.
Publicado: (2015)

Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis
por: El-Banna, Hassan, et al.
Publicado: (2014)

Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies
por: Vignesh, Ammapati Paul Pandian, et al.
Publicado: (2015)

Anti-Cyclic Citrullinated Peptide Antibody and Periodontal Status in Rheumatoid Arthritis Patients
por: Mohamad, Wan Majdiah Wan, et al.
Publicado: (2018)

Anti–Cyclic Citrullinated Peptide Antibody as a Predictor of Rheumathoid Arthritis Complications
por: Mekic, Mevludin, et al.
Publicado: (2020)

Salivary anti-cyclic citrullinated peptide as a screening tool for rheumatoid arthritis
por: Mortazavi, Nazanin, et al.
Publicado: (2022)

Erratum: Asbestos exposure and autoantibody titers
por: Lee, Eunsoo, et al.
Publicado: (2021)

Validation of a multiplex chip-based assay for the detection of autoantibodies against citrullinated peptides
por: Hansson, Monika, et al.
Publicado: (2012)

Evaluation of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Omani Patients with Rheumatoid Arthritis
por: Al-Shukaili, Ahmed, et al.
Publicado: (2012)

Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis
por: Alexiou, Ioannis, et al.
Publicado: (2007)

Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?
por: De Rooy, Diederik PC, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9vklgoor3o3600j2qk58hnvlvq